These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16189154

  • 1. Gene amplification and protein expression of EGFR and HER2 by chromogenic in situ hybridisation and immunohistochemistry in atypical adenomatous hyperplasia and adenocarcinoma of the lung.
    Awaya H, Takeshima Y, Furonaka O, Kohno N, Inai K.
    J Clin Pathol; 2005 Oct; 58(10):1076-80. PubMed ID: 16189154
    [Abstract] [Full Text] [Related]

  • 2. Expression of eukaryotic initiation factor 4E in atypical adenomatous hyperplasia and adenocarcinoma of the human peripheral lung.
    Seki N, Takasu T, Mandai K, Nakata M, Saeki H, Heike Y, Takata I, Segawa Y, Hanafusa T, Eguchi K.
    Clin Cancer Res; 2002 Oct; 8(10):3046-53. PubMed ID: 12374671
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB, Chung JH, Lee HJ, Lee CT, Jheon S, Sung SW.
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [Abstract] [Full Text] [Related]

  • 4. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G, Cavazza A, Bertolini F, Longo L, Marchioni A, Costantini M, Barbieri F, Migaldi M, Rossi G.
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [Abstract] [Full Text] [Related]

  • 5. Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.
    Yoshida Y, Shibata T, Kokubu A, Tsuta K, Matsuno Y, Kanai Y, Asamura H, Tsuchiya R, Hirohashi S.
    Lung Cancer; 2005 Oct; 50(1):1-8. PubMed ID: 15950315
    [Abstract] [Full Text] [Related]

  • 6. Detection of epidermal growth factor receptor and human epidermal growth factor receptor 2 activating mutations in lung adenocarcinoma by high-resolution melting amplicon analysis: correlation with gene copy number, protein expression, and hormone receptor expression.
    Willmore-Payne C, Holden JA, Layfield LJ.
    Hum Pathol; 2006 Jun; 37(6):755-63. PubMed ID: 16733218
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
    Sakamoto H, Shimizu J, Horio Y, Ueda R, Takahashi T, Mitsudomi T, Yatabe Y.
    J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
    [Abstract] [Full Text] [Related]

  • 11. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study.
    Hirsch FR, Varella-Garcia M, McCoy J, West H, Xavier AC, Gumerlock P, Bunn PA, Franklin WA, Crowley J, Gandara DR, Southwest Oncology Group.
    J Clin Oncol; 2005 Oct 01; 23(28):6838-45. PubMed ID: 15998906
    [Abstract] [Full Text] [Related]

  • 12. Loss of expression of E-cadherin and beta-catenin is associated with progression of pulmonary adenocarcinoma.
    Awaya H, Takeshima Y, Amatya VJ, Ishida H, Yamasaki M, Kohno N, Inai K.
    Pathol Int; 2005 Jan 01; 55(1):14-8. PubMed ID: 15660698
    [Abstract] [Full Text] [Related]

  • 13. Gene amplification of ERBB2 and EGFR in adenocarcinoma in situ and intramucosal adenocarcinoma of Barrett's esophagus.
    Ooi A, Zen Y, Ninomiya I, Tajiri R, Suzuki S, Kobayashi H, Imoto I, Dobashi Y.
    Pathol Int; 2010 Jun 01; 60(6):466-71. PubMed ID: 20518902
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung.
    Haneda H, Sasaki H, Shimizu S, Endo K, Suzuki E, Yukiue H, Kobayashi Y, Yano M, Fujii Y.
    Lung Cancer; 2006 Apr 01; 52(1):47-52. PubMed ID: 16503085
    [Abstract] [Full Text] [Related]

  • 16. Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma.
    Dacic S, Flanagan M, Cieply K, Ramalingam S, Luketich J, Belani C, Yousem SA.
    Am J Clin Pathol; 2006 Jun 01; 125(6):860-5. PubMed ID: 16690485
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
    Sakuma Y, Matsukuma S, Yoshihara M, Nakamura Y, Noda K, Nakayama H, Kameda Y, Tsuchiya E, Miyagi Y.
    Am J Clin Pathol; 2007 Jul 01; 128(1):100-8. PubMed ID: 17580276
    [Abstract] [Full Text] [Related]

  • 19. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
    Kerr KM, MacKenzie SJ, Ramasami S, Murray GI, Fyfe N, Chapman AD, Nicolson MC, King G.
    J Pathol; 2004 Jun 01; 203(2):638-44. PubMed ID: 15141378
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.